Mimedx (MDXG) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.15% |
| Dec 31, 2025 | 29.83% |
| Sep 30, 2025 | 30.79% |
| Jun 30, 2025 | 26.47% |
| Mar 31, 2025 | 21.99% |
| Dec 31, 2024 | 10.40% |
| Sep 30, 2024 | 29.03% |
| Jun 30, 2024 | 30.51% |
| Mar 31, 2024 | 31.83% |
| Dec 31, 2023 | 39.44% |
| Sep 30, 2023 | 9.39% |
| Jun 30, 2023 | 4.57% |
| Mar 31, 2023 | -3.60% |
| Dec 31, 2022 | -8.78% |
| Sep 30, 2022 | -4.28% |
| Jun 30, 2022 | -9.87% |
| Mar 31, 2022 | -8.58% |
| Dec 31, 2021 | -6.98% |
| Sep 30, 2021 | -15.38% |
| Jun 30, 2021 | 24.01% |
| Mar 31, 2021 | 20.08% |
| Dec 31, 2020 | 20.86% |
| Sep 30, 2020 | 19.00% |
| Jun 30, 2020 | -11.39% |
| Mar 31, 2020 | 47.90% |
| Dec 31, 2019 | 36.08% |
| Dec 31, 2018 | 1.31% |
| Dec 31, 2017 | 3.39% |
| Sep 30, 2017 | -1.63% |
| Jun 30, 2017 | 12.88% |
| Mar 31, 2017 | 6.36% |
| Dec 31, 2016 | -13.71% |
| Sep 30, 2016 | 44.26% |
| Jun 30, 2016 | 55.53% |
| Mar 31, 2016 | 67.02% |
| Dec 31, 2015 | 24.40% |
| Sep 30, 2015 | 29.40% |
| Jun 30, 2015 | 32.33% |
| Mar 31, 2015 | 21.47% |
| Dec 31, 2014 | 29.00% |
| Sep 30, 2014 | 114.85% |
| Jun 30, 2014 | 113.55% |
| Mar 31, 2014 | 130.76% |
| Dec 31, 2013 | 140.73% |
| Sep 30, 2013 | 35.07% |
| Jun 30, 2013 | 46.63% |
| Mar 31, 2013 | 40.92% |
| Dec 31, 2012 | 29.84% |
| Sep 30, 2012 | 42.39% |
| Jun 30, 2012 | 13.13% |
| Dec 31, 2011 | 268.54% |